WO1998000539A3 - (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip) - Google Patents
(mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip) Download PDFInfo
- Publication number
- WO1998000539A3 WO1998000539A3 PCT/US1997/010866 US9710866W WO9800539A3 WO 1998000539 A3 WO1998000539 A3 WO 1998000539A3 US 9710866 W US9710866 W US 9710866W WO 9800539 A3 WO9800539 A3 WO 9800539A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- kinase
- mip
- mkk3
- protein
- mitogen
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 102000043136 MAP kinase family Human genes 0.000 title abstract 2
- 108091054455 MAP kinase family Proteins 0.000 title abstract 2
- 230000004913 activation Effects 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 abstract 1
- 210000000496 pancreas Anatomy 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
- 230000026683 transduction Effects 0.000 abstract 1
- 238000010361 transduction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU43260/97A AU4326097A (en) | 1996-07-03 | 1997-07-02 | (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip) |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2122496P | 1996-07-03 | 1996-07-03 | |
US60/021,224 | 1996-07-03 | ||
US2164196P | 1996-07-12 | 1996-07-12 | |
US60/021,641 | 1996-07-12 | ||
US88657297A | 1997-07-01 | 1997-07-01 | |
US08/886,572 | 1997-07-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1998000539A2 WO1998000539A2 (en) | 1998-01-08 |
WO1998000539A3 true WO1998000539A3 (en) | 1998-03-26 |
Family
ID=27361599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/010866 WO1998000539A2 (en) | 1996-07-03 | 1997-07-02 | (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4326097A (en) |
WO (1) | WO1998000539A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756332A (en) * | 1996-12-26 | 1998-05-26 | Incyte Pharmaceuticals, Inc. | Guanosine monophosphate reductase |
US6372473B1 (en) | 1997-05-28 | 2002-04-16 | Human Genome Sciences, Inc. | Tissue plasminogen activator-like protease |
US6165461A (en) * | 1998-04-14 | 2000-12-26 | Board Of Regents, University Of Texas System | Tao protein kinases and methods of use therefor |
JP2004521892A (en) | 2000-12-20 | 2004-07-22 | メルク エンド カムパニー インコーポレーテッド | (Halo-benzocarbonyl) heterocyclic fused phenyl p38 kinase inhibitors |
-
1997
- 1997-07-02 WO PCT/US1997/010866 patent/WO1998000539A2/en active Application Filing
- 1997-07-02 AU AU43260/97A patent/AU4326097A/en not_active Abandoned
Non-Patent Citations (5)
Title |
---|
B. DÉRIJARD ET AL.: "Independent Human MAP kinase signal transduction pathways defined by MEK and MKK isoforms.", SCIENCE, vol. 267, 3 February 1995 (1995-02-03), pages 682 - 685, XP002054336 * |
H. KANNO ET AL.: "Two structural genes on different chromosomes are required for encoding the major subunit of human cell glucose-6-phosphate dehydrogenase.", CELL, vol. 58, 11 August 1989 (1989-08-11), pages 595 - 606, XP002054262 * |
S. HENIKOFF ET AL.: "The human mRNA that provides the N-terminus of chimeric G6PD encodes GMP reductase.", CELL, vol. 58, 22 September 1989 (1989-09-22), pages 1021 - 1022, XP002054263 * |
T. KONDOH ET AL.: "Genomic structure and expression of human guanosine monophosphate reductase.", HUMAN GENETICS, vol. 88, 1991, pages 219 - 224, XP002054264 * |
Z. XIA ET AL.: "Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis.", SCIENCE, vol. 270, 24 November 1995 (1995-11-24), pages 1326 - 1331, XP002054337 * |
Also Published As
Publication number | Publication date |
---|---|
AU4326097A (en) | 1998-01-21 |
WO1998000539A2 (en) | 1998-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2253238A1 (en) | Novel agouti-related gene | |
CA2162397A1 (en) | Ligands for flt3 receptors | |
WO1992013878A3 (en) | Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same | |
WO1998030693A3 (en) | Tumor necrosis factor receptor 5 | |
CA2158750A1 (en) | Monoclonal antibodies to casein kinase i polypeptides | |
WO2002083675A3 (en) | Inhibitors of akt activity | |
WO1999040189A3 (en) | Cdnas encoding secreted proteins | |
WO2001070977A3 (en) | Fibroblast growth factor receptor-like molecules and uses thereof | |
WO1999048868A3 (en) | Heterocyclic classes of compounds for the modulating tyrosine protein kinase | |
CA2295999A1 (en) | Nik proteins, nucleic acids and methods | |
WO2000012726A3 (en) | Rationally designed heparinases derived from heparinase i and ii | |
AU2868099A (en) | Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby | |
AU3563199A (en) | Seed specific polycomb group gene and methods of use for same | |
WO2001068854A3 (en) | Fibroblast growth factor-like molecules and uses thereof | |
WO1996007739A3 (en) | Interleukin-1 type 3 receptors | |
AU2001287040A1 (en) | Methods of designing and producing novel compounds having improved binding affinity for cd154 or other trimeric proteins | |
WO1998000539A3 (en) | (mitogen-activated protein kinase) kinase-3 (mkk3) interacting protein (mip) | |
WO2001042474A3 (en) | Interferon-like molecules and uses thereof | |
WO2002090524A3 (en) | Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof | |
AU6282896A (en) | Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins | |
AU2458988A (en) | The preparation, by genetic manipulation, of anticoagulative protein pp4 | |
CA2260765A1 (en) | Purified proteins, recombinant dna sequences and processes for controlling the ripening of coffee plants | |
WO1994017189A3 (en) | Protein kinases | |
AU1755092A (en) | Preparation of 3'-substituted-2',3'-dideoxynucleosides and 2'-deoxynucleosides from acyclic, achiral precursors | |
WO1999038981A3 (en) | Human protein kinase molecules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 98504231 Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |